Product
Long DOAC
1 clinical trial
3 indications
Indication
Venous ThrombosisIndication
CancerIndication
Blood thinnersClinical trial
Optimal Duration of Anticoagulation Therapy for Low-risk Pulmonary Embolism Patients With CancerStatus: Active (not recruiting), Estimated PCD: 2024-09-30